From Gig Harbor, Washington, USA:
What are your thoughts on the new insulin, glargine, just approved by the FDA, produced by Aventis Pharmaceuticals? Will it replace the need for the pump?
Lantus (insulin glargine), is a promising new insulin for the management of diabetes. Given once a day at bedtime, it is equivalent to two doses of NPH, but it does have to be given in a separate syringe. At this stage, it is difficult to predict what will be the most popular modalities for insulin in achieving meticulous control in the years to come. Pumps are being increasingly used, and they will get a further boost when they can be combined with some kind of subcutaneous or intraperitoneal glucose sensor like those being planned by Animas Corporation, Disetronic Medical Systems, MiniMed, Inc., and other companies. There will still be some people though who find pumps cosmetically awkward or just cumbersome who will still achieve excellent control with lispro at meal times and glargine at bedtime.
Last Updated: Tuesday April 06, 2010 15:09:14
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2017. Comments and Feedback.